About Stephen Farr
Form D filings for Mahzi Therapeutics in 2024 list Stephen Farr as director.
Stephen Farr first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Farr in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Farr works with at each company, as listed on that company's latest Form D.
Mahzi Therapeutics Inc. · Form D/A, Jul 8, 2024
CS
Camille Samuels
Director
SS
Shalini Sharp
Director
MS
Marten Steen
Director
YW
Yael Weiss
Chief Executive Officer and director